Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis

Clinical trial NCT06686472 · RECRUITING

Trial details

NCT number: NCT06686472
Sponsor: Telios Pharma, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2024-10-03
Primary completion: 2024-12-10
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.